Wikipedia:Choosing Wisely/American Society for Clinical Pathology
The Choosing Wisely campaign will publish information from this society in late February 2013. Before then, there is no available information available except that this society is participating in the campaign and intends to share five ideas which its members have chosen as important for doctors and patients to discuss.
"(test) indicated in patients with high risk for vitamin D deficiency and when the results of the test would be used as supporting evidence for beginning aggressive therapies"
*An arbitrary month has been chosen to present a count of pageviews. This month is neither the busiest nor slowest month, and this number seems typical for most articles in most months. Through the link anyone may check traffic in other months.
Sattar, N.; Welsh, P.; Panarelli, M.; Forouhi, N. G. (2012). "Increasing requests for vitamin D measurement: Costly, confusing, and without credibility". The Lancet. 379 (9811): 95–96. doi:10.1016/S0140-6736(11)61816-3. PMID22243814.
Bilinski, K. L.; Boyages, S. C. (2012). "The rising cost of vitamin D testing in Australia: Time to establish guidelines for testing". The Medical Journal of Australia. 197 (2): 90. doi:10.5694/mja12.10561. PMID22794049.
Lu, Chuanyi M. (May 2012). "Pathology consultation on vitamin D testing: Clinical indications for 25(OH) vitamin D measurement [Letter to the editor]". American Journal Clinical Pathology (137). American Society for Clinical Pathology: 831–832., which cites
Arya, S. C.; Agarwal, N. (2012). "Pathology Consultation on Vitamin D Testing: Clinical Indications for 25(OH) Vitamin D Measurement". American Journal of Clinical Pathology. 137 (5): 832. doi:10.1309/AJCP2GP0GHKQRCOE. PMID22523224.
Holick, M. F.; Binkley, N. C.; Bischoff-Ferrari, H. A.; Gordon, C. M.; Hanley, D. A.; Heaney, R. P.; Murad, M. H.; Weaver, C. M. (2011). "Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline". Journal of Clinical Endocrinology & Metabolism. 96 (7): 1911–1930. doi:10.1210/jc.2011-0385. PMID21646368.
Lee, J. W. Y.; Berkowitz, Z.; Saraiya, M. (2011). "Low-Risk Human Papillomavirus Testing and Other Nonrecommended Human Papillomavirus Testing Practices Among U.S. Health Care Providers". Obstetrics & Gynecology. 118 (1): 4–13. doi:10.1097/AOG.0b013e3182210034. PMID21691157.
Zhao, C.; Chen, X.; Onisko, A.; Kanbour, A.; Austin, R. M. (2011). "Follow-up outcomes for a large cohort of US women with negative imaged liquid-based cytology findings and positive high risk human papillomavirus test results". Gynecologic Oncology. 122 (2): 291–296. doi:10.1016/j.ygyno.2011.04.037. PMID21601911.
American Society for Colposcopy and Cervical Pathology (2009), Descriptions of New FDA-approved HPV DNA Tests, American Society for Colposcopy and Cervical Pathology, retrieved 23 October 2013{{citation}}: Cite has empty unknown parameter: |1= (help)
Keay, L.; Lindsley, K.; Tielsch, J.; Katz, J.; Schein, O. (2009). Keay, Lisa (ed.). "Routine preoperative medical testing for cataract surgery". The Cochrane Library (2): CD007293. doi:10.1002/14651858.CD007293.pub2. PMID19370681.
Katz, R. I.; Dexter, F.; Rosenfeld, K.; Wolfe, L.; Redmond, V.; Agarwal, D.; Salik, I.; Goldsteen, K.; Goodman, M.; Glass, P. S. A. (2011). "Survey Study of Anesthesiologistsʼ and Surgeonsʼ Ordering of Unnecessary Preoperative Laboratory Tests". Anesthesia & Analgesia. 112 (1): 207–212. doi:10.1213/ANE.0b013e31820034f0. PMID21081771.
Munro, J.; Booth, A.; Nicholl, J. (1997). "Routine preoperative testing: A systematic review of the evidence". Health technology assessment (Winchester, England). 1 (12): i–iv, 1–62. PMID9483155.
Reynolds, T. M.; National Institute for Health Clinical Excellence; Clinical Scince Reviews Committee of the Association for Clinical Biochemistry (2006). "National Institute for Health and Clinical Excellence guidelines on preoperative tests: The use of routine preoperative tests for elective surgery". Annals of Clinical Biochemistry. 43 (Pt 1): 13–16. doi:10.1258/000456306775141623. PMID16390604.
Church, T. R.; Wandell, M.; Lofton–Day, C.; Mongin, S.; Blumenstein, B. A.; Allen, J. I.; Roesch, T.; Snover, D.; Day, R.; Ransohoff, D. F.; Poordad, F.; Lawitz, E. J.; McCone, J.; Shiffman, M. L.; Galler, G. W.; Lee, W. M.; Reindollar, R.; King, J. W.; Kwo, P. Y.; Ghalib, R. H.; Freilich, B.; Nyberg, L. M.; Zeuzem, S.; Poynard, T.; Vock, D. M.; Pieper, K. S.; Patel, K.; Tillmann, H. L.; Noviello, S.; Koury, K. (2010). "Prospective Clinical Validation of an Assay for Methylated SEPT9 DNA in Human Plasma as a Colorectal Cancer Screening Tool in Average Risk Men and Women ≥50 Years". Gastroenterology. 139 (1): 120–129.e18. doi:10.1053/j.gastro.2010.05.068.
Ahlquist, D. A.; Taylor, W. R.; Mahoney, D. W.; Zou, H.; Domanico, M.; Thibodeau, S. N.; Boardman, L. A.; Berger, B. M.; Lidgard, G. P. (2012). "The Stool DNA Test is More Accurate Than the Plasma Septin 9 Test in Detecting Colorectal Neoplasia". Clinical Gastroenterology and Hepatology. 10 (3): 272–277.e1. doi:10.1016/j.cgh.2011.10.008. PMID22019796.
Lehman, C. M.; Blaylock, R. C.; Alexander, D. P.; Rodgers, G. M. (2001). "Discontinuation of the bleeding time test without detectable adverse clinical impact". Clinical chemistry. 47 (7): 1204–1211. PMID11427450.
Peterson, P.; Hayes, T. E.; Arkin, C. F.; Bovill, E. G.; Fairweather, R. B.; Rock Jr, W. A.; Triplett, D. A.; Brandt, J. T. (1998). "The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article". Archives of Surgery. 133 (2): 134–139. doi:10.1001/archsurg.133.2.134. PMID9484723.
Lind, S. E. (1991). "The bleeding time does not predict surgical bleeding". Blood. 77 (12): 2547–2552. PMID2043759.